Neurologic toxicity of intrathecal liposomal cytarabine when used for CNS prophylaxis in conjunction with the hyper-CVAD regimen [2]

Deborah A Thomas; Elias Jabbour; Hagop Kantarjian; Susan O'Brien

doi:10.1182/blood-2007-04-081745

Neurologic toxicity of intrathecal liposomal cytarabine when used for CNS prophylaxis in conjunction with the hyper-CVAD regimen [2]

Deborah A Thomas, Elias Jabbour, Hagop Kantarjian, Susan O'Brien

Leukemia

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	1698-1699
Number of pages	2
Journal	Blood
Volume	110
Issue number	5
DOIs	https://doi.org/10.1182/blood-2007-04-081745
State	Published - Sep 1 2007

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2007-04-081745

Cite this

@article{caf28cb4179c4a078e175ec49b5233bc,

title = "Neurologic toxicity of intrathecal liposomal cytarabine when used for CNS prophylaxis in conjunction with the hyper-CVAD regimen [2]",

author = "Thomas, {Deborah A} and Elias Jabbour and Hagop Kantarjian and Susan O'Brien",

year = "2007",

month = sep,

day = "1",

doi = "10.1182/blood-2007-04-081745",

language = "English (US)",

volume = "110",

pages = "1698--1699",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "5",

}

TY - JOUR

T1 - Neurologic toxicity of intrathecal liposomal cytarabine when used for CNS prophylaxis in conjunction with the hyper-CVAD regimen [2]

AU - Thomas, Deborah A

AU - Jabbour, Elias

AU - Kantarjian, Hagop

AU - O'Brien, Susan

PY - 2007/9/1

Y1 - 2007/9/1

UR - http://www.scopus.com/inward/record.url?scp=34548814708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548814708&partnerID=8YFLogxK

U2 - 10.1182/blood-2007-04-081745

DO - 10.1182/blood-2007-04-081745

M3 - Letter

AN - SCOPUS:34548814708

SN - 0006-4971

VL - 110

SP - 1698

EP - 1699

JO - Blood

JF - Blood

IS - 5

ER -

Neurologic toxicity of intrathecal liposomal cytarabine when used for CNS prophylaxis in conjunction with the hyper-CVAD regimen [2]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this